PTC Therapeutics Inc
Sector: Manufacturing
Industry: Pharmaceutical Products
42.51
1.75
(4.29%)
Volume:
2,128,395
52 week range:
28.72 - 58.38
Market Cap:
3.369B
Company Description:
PTC Therapeutics focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. The company offers Translarna and Emflaza for the treatment of Duchenne muscular dystrophy in the European Economic Area and the United States; Tegsedi and Waylivra for the. treatment of rare diseases in Latin America and the Caribbean. PTC518 is being developed for Huntington's disease.